"Pharma Wholesale and Distribution Market Will Reach $747bn in 2014" Visiongain Report Predicts
A new report by visiongain predicts that the world market for pharmaceutical wholesale and distribution (W&D) activities will reach $747 billion for 2014. That revenue forecast appears in Pharma Wholesale and Distribution Market: World Outlook 2012-2022, published in June 2012. Visiongain is a business information provider based in London, UK.
London, United Kingdom, June 21, 2012 --(PR.com)-- The pharma industry and its supply chain partners will increase revenues from 2012 to 2022. New products – novel small molecules, generics and biologics – will stimulate the pharma W&D market. Many opportunities for rising drug sales exist, with high, growing W&D revenues possible from 2012 to 2022. There will be increasing dependence on emerging countries, with their fast-rising drug sales. Developed countries hold promise too, the study notes.
Kritika Chaudhari, a pharmaceutical industry analyst in visiongain, explains: “Growth in the global pharmaceutical wholesale and distribution market to 2022 will be driven by the ageing world population and increasing demand for medicines of all types.
“Pharmaceutical wholesalers and distributors play an important role in connecting drug manufacturers to final buyers. A number of blockbuster drugs are going off patent in the next few years, which will threaten revenue generation. Nevertheless, the worldwide wholesale and distribution market will continue to grow as a result of increasing demand for novel drugs.”
Visiongain’s report provides revenue forecasts to 2022 at world market, submarket, company and national level. It forecasts world sales for the following main submarkets:
• Original-branded drugs
• Generic drugs
Research, data and analyses cover activities of McKesson, Cardinal Health, AmerisourceBergen, The PHOENIX Group and other companies, with revenue forecasts. The scope of the field widens, with organisations collaborating and expanding their businesses.
The study discusses business activities and commercial news, shows research interviews with external authorities and forecasts revenues in leading national markets. The work analyses the US, Japan, EU5 countries, Brazil, Russia, China and India.
Pharma Wholesale and Distribution Market: World Outlook 2012-2022 adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For sample pages and further information concerning the Visiongain report Pharma Wholesale and Distribution Market: World Outlook 2012-2022 please visit: http://www.visiongain.com/Report/839/Pharma-Wholesale-and-Distribution-Market-World-Outlook-2012-2022
For an exec summary of this report or to order it today, please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100
About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
Kritika Chaudhari, a pharmaceutical industry analyst in visiongain, explains: “Growth in the global pharmaceutical wholesale and distribution market to 2022 will be driven by the ageing world population and increasing demand for medicines of all types.
“Pharmaceutical wholesalers and distributors play an important role in connecting drug manufacturers to final buyers. A number of blockbuster drugs are going off patent in the next few years, which will threaten revenue generation. Nevertheless, the worldwide wholesale and distribution market will continue to grow as a result of increasing demand for novel drugs.”
Visiongain’s report provides revenue forecasts to 2022 at world market, submarket, company and national level. It forecasts world sales for the following main submarkets:
• Original-branded drugs
• Generic drugs
Research, data and analyses cover activities of McKesson, Cardinal Health, AmerisourceBergen, The PHOENIX Group and other companies, with revenue forecasts. The scope of the field widens, with organisations collaborating and expanding their businesses.
The study discusses business activities and commercial news, shows research interviews with external authorities and forecasts revenues in leading national markets. The work analyses the US, Japan, EU5 countries, Brazil, Russia, China and India.
Pharma Wholesale and Distribution Market: World Outlook 2012-2022 adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For sample pages and further information concerning the Visiongain report Pharma Wholesale and Distribution Market: World Outlook 2012-2022 please visit: http://www.visiongain.com/Report/839/Pharma-Wholesale-and-Distribution-Market-World-Outlook-2012-2022
For an exec summary of this report or to order it today, please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100
About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
Contact
Visiongain
Sara Peerun
+44 020 7336 6100
www.visiongain.com
Contact
Sara Peerun
+44 020 7336 6100
www.visiongain.com
Categories